Conmed (NYSE:CNMD) reported its Q3 earnings results on Wednesday, October 27, 2021 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Conmed beat their estimated earnings by 5.26%, reporting an EPS of $0.8 versus an estimate of $0.76, which did not surprise analysts.
Revenue was up $10,992,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.09, which was followed by a 0.77% drop in the share price the next day.
Here’s a look at Conmed’s past performance:
| Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.62 | 0.44 | 0.76 | 0.23 |
| EPS Actual | 0.71 | 0.63 | 0.84 | 0.88 |
| Revenue Estimate | 248.31M | 216.88M | 262.94M | 205.92M |
| Revenue Actual | 255.16M | 232.68M | 252.83M | 237.84M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
